TEL AVIV, Israel and MIAMI, April 03, 2024 InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today announced that Marvin Slosman, Chief.
Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat.
/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development.
ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney. | May 11, 2023